BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 9696366)

  • 21. Chemical meningitis related to intra-CSF liposomal cytarabine.
    Durand B; Zairi F; Boulanger T; Bonneterre J; Mortier L; Le Rhun E
    CNS Oncol; 2017 Oct; 6(4):261-267. PubMed ID: 29057672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leptomeningeal metastases: a review of evaluation and treatment.
    Chamberlain MC
    J Neurooncol; 1998 May; 37(3):271-84. PubMed ID: 9524085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leptomeningeal metastasis.
    Chamberlain MC
    Semin Neurol; 2010 Jul; 30(3):236-44. PubMed ID: 20577930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current diagnosis and treatment of leptomeningeal metastasis.
    DeAngelis LM
    J Neurooncol; 1998; 38(2-3):245-52. PubMed ID: 9696379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central nervous system relapse of systemic non-Hodgkin's lymphoma: results of treatment based on high-dose methotrexate combination chemotherapy.
    Bokstein F; Lossos A; Lossos IS; Siegal T
    Leuk Lymphoma; 2002 Mar; 43(3):587-93. PubMed ID: 12002763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukemic and lymphomatous meningitis: incidence, prognosis and treatment.
    Chamberlain MC; Nolan C; Abrey LE
    J Neurooncol; 2005 Oct; 75(1):71-83. PubMed ID: 16215818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical improvement and survival in breast cancer leptomeningeal metastasis correlate with the cytologic response to intrathecal chemotherapy.
    Clatot F; Philippin-Lauridant G; Ouvrier MJ; Nakry T; Laberge-Le-Couteulx S; Guillemet C; Veyret C; Blot E
    J Neurooncol; 2009 Dec; 95(3):421-426. PubMed ID: 19557501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of compassionate therapy with intrathecal depot liposomal cytarabine in acute myeloid leukemia meningeosis.
    Sancho JM; Deben G; Parker A; Piñana JL; Bolam S; Sánchez-García E; Giménez E; Pascual T; Fernández-Abellán P; Palomera L; Ribera JM
    Int J Hematol; 2007 Jul; 86(1):33-6. PubMed ID: 17675264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salvage intracerebrospinal fluid thiotepa in breast cancer-related leptomeningeal metastases: a retrospective case series.
    Le Rhun E; Taillibert S; Devos P; Zairi F; Turpin A; Rodrigues I; Cazin JL; Pierret MF; André C; Dubois F; Bonneterre J; Chamberlain MC
    Anticancer Drugs; 2013 Nov; 24(10):1093-7. PubMed ID: 23962903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxicity of treatment for neoplastic meningitis.
    Siegal T
    Curr Oncol Rep; 2003 Jan; 5(1):41-9. PubMed ID: 12493149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrathecal chemotherapy.
    Kerr JZ; Berg S; Blaney SM
    Crit Rev Oncol Hematol; 2001 Mar; 37(3):227-36. PubMed ID: 11248578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoplastic meningitis from breast cancer: feasibility and activity of long-term intrathecal liposomal Ara-C combined with dose-dense temozolomide.
    Hoffmann AL; Buhk JH; Strik H
    Anticancer Res; 2009 Dec; 29(12):5191-5. PubMed ID: 20044635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylaxis and treatment of leptomeningeal carcinomatosis in solid tumors of adulthood.
    Hildebrand J
    J Neurooncol; 1998; 38(2-3):193-8. PubMed ID: 9696371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New strategies in the management of leptomeningeal metastases.
    Groves MD
    Arch Neurol; 2010 Mar; 67(3):305-12. PubMed ID: 20212228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study.
    Boogerd W; van den Bent MJ; Koehler PJ; Heimans JJ; van der Sande JJ; Aaronson NK; Hart AA; Benraadt J; Vecht ChJ
    Eur J Cancer; 2004 Dec; 40(18):2726-33. PubMed ID: 15571954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leptomeningeal metastasis.
    Chamberlain MC
    Curr Opin Neurol; 2009 Dec; 22(6):665-74. PubMed ID: 19738466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcome and efficacy of current anti-leukemic therapy for leptomeningeal involvement in acute myeloid leukemia.
    Kwon JH; Koh YI; Yoon SS; Park S; Kim I
    Int J Hematol; 2016 Nov; 104(5):574-581. PubMed ID: 27431487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical trial of intrathecal administration of 5-fluoro-2'-deoxyuridine for treatment of meningeal dissemination of malignant tumors.
    Nakagawa H; Yamada M; Maeda N; Iwatsuki K; Hirayama A; Ikenaka K
    J Neurooncol; 1999; 45(2):175-83. PubMed ID: 10778733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current treatment approaches for neoplastic meningitis: nursing management of patients receiving intrathecal DepoCyt.
    Craig C
    Oncol Nurs Forum; 2000 Sep; 27(8):1225-30; quiz 1231-2. PubMed ID: 11013903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sanctuary site leptomeningeal metastases in HER-2 positive breast cancer: A review in the era of trastuzumab.
    Kordbacheh T; Law WY; Smith IE
    Breast; 2016 Apr; 26():54-8. PubMed ID: 27017242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.